Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 13 studies | 27% ± 7% | |
| astrocyte | 5 studies | 33% ± 15% |
Insufficient scRNA-seq data for expression of MOXD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 98% | 2778.06 | 241 / 245 | 93% | 24.59 | 468 / 502 |
| lung | 100% | 3792.81 | 576 / 578 | 84% | 26.19 | 972 / 1155 |
| adrenal gland | 100% | 2878.62 | 258 / 258 | 68% | 44.77 | 157 / 230 |
| skin | 98% | 1867.77 | 1781 / 1809 | 66% | 55.19 | 313 / 472 |
| esophagus | 100% | 2547.96 | 1439 / 1445 | 55% | 12.75 | 101 / 183 |
| uterus | 95% | 5359.01 | 162 / 170 | 54% | 19.14 | 246 / 459 |
| intestine | 91% | 1561.52 | 881 / 966 | 47% | 7.46 | 248 / 527 |
| kidney | 90% | 3130.80 | 80 / 89 | 42% | 8.23 | 375 / 901 |
| bladder | 81% | 1805.29 | 17 / 21 | 49% | 8.26 | 247 / 504 |
| stomach | 52% | 469.46 | 187 / 359 | 55% | 11.60 | 156 / 286 |
| pancreas | 16% | 104.73 | 53 / 328 | 90% | 30.32 | 160 / 178 |
| brain | 57% | 889.44 | 1513 / 2642 | 41% | 23.99 | 290 / 705 |
| breast | 32% | 181.86 | 146 / 459 | 57% | 8.25 | 636 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 76% | 34.47 | 34 / 45 |
| spleen | 63% | 356.38 | 152 / 241 | 0% | 0 | 0 / 0 |
| thymus | 37% | 198.88 | 243 / 653 | 23% | 2.42 | 137 / 605 |
| heart | 48% | 339.92 | 413 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 4.58 | 13 / 29 |
| adipose | 39% | 255.98 | 473 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 7% | 67.25 | 13 / 180 | 31% | 4.90 | 132 / 430 |
| liver | 6% | 29.77 | 13 / 226 | 18% | 2.44 | 72 / 406 |
| blood vessel | 18% | 120.19 | 234 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 14% | 208.97 | 127 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.47 | 3 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042420 | Biological process | dopamine catabolic process |
| GO_0042421 | Biological process | norepinephrine biosynthetic process |
| GO_0006589 | Biological process | octopamine biosynthetic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0030667 | Cellular component | secretory granule membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0004500 | Molecular function | dopamine beta-monooxygenase activity |
| GO_0005507 | Molecular function | copper ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MOXD1 |
| Protein name | DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X) Monooxygenase DBH like 1 |
| Synonyms | UNQ2493/PRO5780 MOX |
| Description | |
| Accessions | ENST00000336749.3 [Q6UVY6-2] ENST00000392401.3 A6PVS1 Q6UVY6 ENST00000367963.8 [Q6UVY6-1] |